Pharmacosmos A/s
Clinical trials sponsored by Pharmacosmos A/s, explained in plain language.
-
New hope for advanced lung cancer: could trilaciclib extend survival?
Disease control Recruiting nowThis study tests whether adding trilaciclib before standard chemotherapy (topotecan) helps people with extensive-stage small cell lung cancer live longer. About 302 participants will receive either trilaciclib or a placebo before chemo. The goal is to see if trilaciclib improves …
Phase: PHASE4 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 17, 2026 02:08 UTC
-
New Iron-Clearing drug shows promise for blood disorder patients
Disease control Recruiting nowThis study tests a new medication called SP-420 in about 90 adults with transfusion-dependent β-thalassemia or low-risk myelodysplastic syndromes. The goal is to see how well it removes extra iron from the liver and whether it is safe. Participants take the drug three times a wee…
Phase: PHASE2 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 17, 2026 02:05 UTC
-
New IV iron shot could help kids with anemia who Can't take pills
Disease control Recruiting nowThis study tests an intravenous (IV) iron medicine called ferric derisomaltose in children aged 0 to 18 with iron deficiency anemia. It is for kids who either have chronic kidney disease or cannot take or do not respond to oral iron. The goal is to see if one or two IV doses can …
Phase: PHASE3 • Sponsor: Pharmacosmos A/S • Aim: Disease control
Last updated May 14, 2026 12:02 UTC